Event

Vincent Cottin

PhD, MD
Hopital Louis Pradel, Universite de Lyon;Louis Pradel Hosp, Univ of Lyon;Louis Pradel Hospital and Université Claude Bernard Lyon 1;Louis Pradel Hospital, Claude Bernard University Lyon 1

Manuel Quaresma

PharmD
Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, and Center for Interstitial and Rare ;Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, and Center for Interstitial

Michael Kreuter

MD, PhD
Center for Interstitial and Rare Lung Diseases, Pneumology and Respiratory Care Medicine, Thoraxklin;Center for interstitial and rare lung diseases, Pneumology, Thoraxklinik, University of Heidelberg,

Christopher D. Wells

PhD
Decision Resources Group

Marlies Wijsenbeek

MD, PhD
Erasmus MC, University Medical Centre;Erasmus Medical Center;Erasmus University Medical Center

Baher Mounir

B Pharm
Boehringer Ingelheim Pharma GmbH & Co. KG

Leila Zouad-Lejour

MSc
Boehringer Ingelheim Pharma GmbH & Co. KG

Aryeh Fischer

M.D.
Univ of Colorado Denver;University of Colorado School of Medicine

Non-IPF Progressive Fibrosing Interstitial Lung Disease (PF-ILD): The Patient Journey